Pfizer India

Pfizer India Q2 PAT rises to Rs 226 crore on lower costs, price hikes

Its cost of materials consumed fell 2.1% to Rs 94.4 crore, accounting for about 21% of total expenses in the quarter

Biden slams Musk's Twitter buy, says platform responsible for spewing lies

"There's no editors anymore," Biden added. "There's no editors. How do we expect kids to be able to understand what is at stake?"

Pfizer's managing director S Sridhar to take an early retirement

Over the past 14 years, Sridhar has led a number of key leadership positions in Pfizer, including serving as the Chief Financial Officer for a period of eight years

Pfizer sets up drug development centre at Chennai's IIT Research Park

The centre integrates two essential functions under the export-oriented undertaking of Pfizer: Pharmaceutical Sciences (PharmSci) and Global Technology and Engineering (GT&E) Centre of Excellence.

Bata, Pfizer: These MNCs have up to 12% upside despite sanctions on Russia

Pfizer is near its long-term support, which it has defended for the last five years. A rebound can trigger a 10 per cent upside for the stock.

Pradip Shah, ex-consultant to World Bank, appointed Pfizer India chairman

Announcing the appointment, S Sridhar, the managing director of the company, said with Pradip Shah's elevation as the chairman, the firm will work closely with him on matters of strategic importance

Sensex ends 157 pts higher, Nifty reclaims 17,500; ITC surges 5%, L&T 3%

The broader markets logged smart gains for the third straight trading session; Advancing shares outnumbered declining stocks in nearly 2:1 ratio on the BSE

Pfizer tops Q3 forecasts as total coronavirus vaccine sales soar

Pfizer beat third-quarter expectations and raised its 2021 forecast again even as sales of its top product, the COVID-19 vaccine Comirnaty, slipped in the U.S.

Pfizer in the final stages to ink Covid-19 vaccine deal with Centre

Sources close to the developments had indicated earlier that the price for India could be below $10 per dose, or the lowest in the world

Govt exploring local manufacturing of Pfizer, J&J, Moderna vaccines: MEA

"We have also helped expedite the introduction of Sputnik-V vaccines," the external affairs ministry spokesperson Arindam Bagchi told ANI.

Covid vaccine: India may grant indemnity to Pfizer, Moderna, says report

Countries like the US have granted these vaccine makers immunity where they cannot be sued for any adverse effects.

Covid-19 vaccination: Too early to say if booster dose needed, say experts

Pfizer CEO has said a 3rd booster shot likely within a year of vaccination

Covid-19: Pfizer withdraws Emergency Use Authorisation application in India

Pfizer had a meeting with India's drugs regulator on Wednesday and the decision was made after that, the company said.

Pfizer Covid-19 vaccine to have differential pricing across countries

The company's Indian arm has sought emergency use authorisation (EUA) for the Pfizer/BioNTech vaccine against Covid-19 in the country from the Indian drug regulator.

Pfizer seeks emergency-use authorisation for its Covid-19 vaccine in India

Pfizer India has become the first pharma company to seek an emergency-use authorisation for its coronavirus vaccine in the country from DCGI

Pfizer vaccine not coming to India soon as trials yet to be conducted

Pfizer has not yet applied for holding clinical trials on Indian volunteers

UK to be first to clear Pfizer-BioNTech Covid vaccine likely by next week

The U.K. had long signaled it would move fast on any promising vaccine candidate

Indices gain for 2nd day in a row, Sensex up 429 pts; India VIX drops 6%

All that happened in the markets today

Pfizer up 8.5%; parent firm's potential Covid-19 drug shows positive result

Pfizer and Germany's BioNTech are in a race with companies including AstraZeneca Plc, Moderna Inc. to come up with a safe and effective vaccine against Covid-19

Abbott India, Pfizer, L&T Infotech: 11 stocks that may enter F&O segment

The eligibility of stock inclusion in the derivatives / F&O segment is based on the criteria laid down by market regulator Sebi.